The American company, Moderna, announced today, Monday, that the effectiveness of its vaccine against the Coronavirus has proven, according to provisional data for the last phase of clinical tests, its efficacy of 94.5%.
The vaccine manufacturer said that this result was confirmed after 95 people were vaccinated with this vaccine, of whom only 5 it infected, noting that the people who underwent the test received two doses 28 days apart.
What distinguishes this vaccine from its counterpart reached by “Pfizer” and “Bionic”, which has proven its effectiveness by 90%, is that the “Moderna” vaccine does not need during its marketing to be stored at temperatures as low as minus 70 degrees Celsius. Store it in a regular refrigerator for 30 days, and up to six months, at minus 20 degrees Celsius.
Source: Reuters+ rt